Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer

被引:330
作者
Aletti, Giovanni D. [1 ]
Dowdy, Sean C. [1 ]
Podratz, Karl C. [1 ]
Cliby, William A. [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Dept Obstet & Gynecol, Rochester, MN 55905 USA
关键词
ovarian cancer; overall survival; residual disease; short-term morbidity; surgical complexity score;
D O I
10.1016/j.ajog.2007.10.495
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Advanced ovarian cancer (OC) is associated with impaired performance status and comorbidities for many patients. These factors have an impact on the decision to perform extended surgical cytoreduction. However, the trade-off between short-term morbidity and overall survival is complex, and few data are available analyzing the combined effects of these variables. PURPOSE: The purpose of the study was to evaluate the impact of patients' age and American Society of Anesthesiologists (ASA) and surgical complexity score (SCS) on short-term morbidity and overall survival. STUDY DESIGN: Presurgical patient characteristics, surgical procedures performed, and outcomes were assessed in a cohort of consecutive primary OC patients. An SCS from 1 to 3 was developed to adjust for the extent of surgery (simple to complex, respectively). Primary outcomes were 30 day major morbidity (sepsis, thromboembolic, cardiac, or reoperation), 3 month mortality, and overall survival (OS). RESULTS: Two hundred nineteen consecutive patients with stage IIIC-IV OC were included. We observed a correlation between ASA and both short-term morbidity (P = .006) and 3 month mortality (P = .006). Age was independently associated with both short-term morbidity (P = .010) and 3 month mortality (P = .005). SCS correlated directly with morbidity (P <.001) but was not correlated with mortality (P = .266). The independent predictors of morbidity (ASA, age, and SCS) were used to develop risk prediction categories: risk of expected complications ranged from 2.5% to 67.6%, depending on category. Despite the increased risk of complications, however, more complex surgery carried a survival benefit in all the risk groups, owing to the observation that residual disease (RD) and SCS held a prognostic significance independent of age and ASA (P <.001 and P = .001, respectively). CONCLUSION: Because of the survival benefit from lower RD, a less aggressive surgical effort results in poorer OS. However, the risk of complications are substantial for complex surgeries in the highest-risk patients: risk stratification should be used to help plan perioperative care and consider optimal treatment planning.
引用
收藏
页码:676.e1 / 676.e7
页数:7
相关论文
共 14 条
[1]  
ALBERTS DS, 1993, CANCER-AM CANCER SOC, V71, P618
[2]   Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon [J].
Aletti, GD ;
Gostout, BS ;
Podratz, KC ;
Cliby, WA .
GYNECOLOGIC ONCOLOGY, 2006, 100 (01) :33-37
[3]   Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer [J].
Aletti, Giovanni D. ;
Dowdy, Sean ;
Podratz, Karl C. ;
Cliby, William A. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) :1862-1868
[4]  
Announcements, 1989, Gynecologic Oncology, V35, P125, DOI [DOI 10.1016/0090-8258(89)90027-9, 10.1016/0090-8258(89)90027-9]
[5]  
[Anonymous], 1975, SEER CANC STAT REV
[6]   Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only? [J].
Cliby, William A. ;
Aletti, Giovanni D. ;
Wilson, Timothy O. ;
Podratz, Karl C. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (03) :797-801
[7]   Management of ovarian cancer in patients older than 80 years of age [J].
Cloven, NG ;
Manetta, A ;
Berman, ML ;
Kohler, MF ;
DiSaia, PJ .
GYNECOLOGIC ONCOLOGY, 1999, 73 (01) :137-139
[8]   Surgical care of elderly women with ovarian cancer:: A population-based perspective [J].
Díaz-Montes, TP ;
Zahurak, ML ;
Gluntoli, RL ;
Gardner, GJ ;
Gordon, TA ;
Armstrong, DK ;
Bristow, RE .
GYNECOLOGIC ONCOLOGY, 2005, 99 (02) :352-357
[9]   CANCER IN THE ELDERLY - WHY SO BADLY TREATED [J].
FENTIMAN, IS ;
TIRELLI, U ;
MONFARDINI, S ;
SCHNEIDER, M ;
FESTEN, J ;
COGNETTI, F ;
AAPRO, MS .
LANCET, 1990, 335 (8696) :1020-1022
[10]  
FENTIMAN IS, 1998, ONCOL PRACT, V2, P12